Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines

Chest

Volumn 129, Issue 1 SUPPL., 2006, Pages 169S-173S

  Dicpinigaitis, Peter V ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Angiotensin receptor blockers; Angiotensin converting enzyme; Angiotensin converting enzyme inhibitors; Bradykinin; Capsaicin; Cough; Prostaglandins; Substance P

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BACLOFEN; BRADYKININ; BRADYKININ RECEPTOR; CAPSAICIN; CROMOGLYCATE DISODIUM; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERROUS SULFATE; INDOMETACIN; NIFEDIPINE; OZAGREL; PICOTAMIDE; PLACEBO; PROSTAGLANDIN; SUBSTANCE P; SULINDAC; THEOPHYLLINE;

CLINICAL TRIAL; COUGHING; DRUG INDUCED DISEASE; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; MEDLINE; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 33144481921     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.1_suppl.169S     Document Type: Article

References (29)

1. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med 1992; 117:234-242
2. Ravid D, Lishner M, Lang R, et al. Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure. J Clin Pharmacol 1994; 34:1116-1120
3. Mello CJ, Irwin RS, Curley FJ. The predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med 1996; 156:997-1003
4. Irwin RS, Curley FJ, French CL. Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outline of specific therapy. Am Rev Respir Dis 1990; 141:640-647
5. Smyrnios NA, Irwin RS, Curley FJ. Chronic cough with a history of excessive sputum production: the spectrum and frequency of causes and key components of the diagnostic evaluation, and outcome of specific therapy. Chest 1995; 108:991-997
6. Os I, Bratland B, Dahlof B, et al. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 1994; 7:1012-1015
7. Coulter DM, Edwards IR. Cough associated with captopril and enalapril. BMJ 1987; 294:1521-1523
8. Strocchi E, Malini PL, Valtancoli G, et al. Cough during treatment with angiotensin converting enzyme inhibitors: analysis of predisposing factors. Drug Invest 1992; 4:69-72
9. Gibson GR. Enalapril-induced cough. Arch Intern Med 1989; 149:2701-2703
10. Woo J, Chan TYK. A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects. Br J Clin Pract 1991; 45:178-180
11. Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol 1995; 40:141-144
12. Morice AH, Lowry R, Brown MJ, et al. Angiotensin-converting enzyme and the cough reflex. Lancet 1987; 2:1116-1118
13. Lacourciere Y, Brunner H, Irwin RS, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. J Hypertens 1994; 12:1387-1393
14. Fox AJ, Lalloo UG, Belvisi MG, et al. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med 1996; 2:814-817
15. Ignjatovic T, Tan F, Brovkovych V, et al. Novel mode of action of angiotensin I converting enzyme inhibitors. J Biol Chem 2002; 277:16847-16852
16. 2 receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough. Hypertension 2000; 36:127-131
17. Dicpinigaitis PV, Dobkin JB. Effect of angiotensin-converting enzyme inhibition on bronchial responsiveness. J Clin Pharmacol 1996; 36:361-364
18. O'Connell F, Thomas VE, Pride NB, et al. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med 1994; 150:374-380
19. Hargreaves MR, Benson MK. Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough. Lancet 1995; 345:13-16
20. Cazolla M, Matera MG, Liccardi G, et al. Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough. Respiration 1993; 60:212-215
21. McEwan JR, Choudry NB, Fuller RW. The effect of sulindac on the abnormal cough reflex associated with dry cough. J Pharmacol Exp Ther 1990; 255:161-164
22. Fogari R, Zoppi A, Mugellini A, et al. Effects of amlodipine, nifedipine GITS, and indomethacin on angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo-controlled, double-masked, crossover study. Curr Ther Res 1999; 60:121-128
23. Lee S-C, Park SW, Kim D-K, et al. Iron supplementation inhibits cough associated with ACE inhibitors. Hypertension 2001; 38:166-170
24. Malini PL, Strocchi E, Zanardi M, et al. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997; 350:15-18
25. Dicpinigaitis PV. Use of baclofen to suppress cough induced by angiotensin-converting enzyme inhibitors. Ann Pharmacother 1996; 30:1242-1245
26. 2 synthetase inhibitor suppresses cough induced by angiotensin converting enzyme inhibitors. Life Sci 1997; 60: 1583-1588
27. Tenenbaum A, Grossman E, Shemesh J, et al. Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens 2000; 13:776-782
28. Pylypchuk GB. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema. Ann Pharmacother 1998; 32:1060-1066
29. Hernandez-Hernandez R, Sosa-Canache B, Velasco M, et al. Angiotensin II receptor antagonists role in arterial hypertension. J Hum Hypertens 2002; 16(suppl):S93-S99